That bottle of pills in the medicine cabinet might be helping one health problem while quietly creating another. Millions of Americans take prescription medications daily without realizing these drugs ...

Granules India share price closed higher today after the firm received approval of a drug from the US drug regulator for treatment of overactive bladder. Share price of Granules India rose up to 5.83% ...

Granules India share price rose 6 percent in the early trade on April 24 after company had received USFDA approval dor drug for the treatment of overactive bladder. The US Food & Drug Administration ...

Living with celiac disease means following a gluten-free diet to improve quality of life. A general rule is to read all food product labels, but there are also less obvious sources of gluten that ...

The trading desk where I started at Deutsche Bank's 280 Park Avenue building (aka "The Old Banker's Trust Building" aka "The Building with the Starbuck's in the Lobby") was a pretty quiet place, and ...

ALLEGAN, MI – Perrigo Company is having a busy spring. Common shares of the store-brand products began trading Thursday in the New York Stock Exchange, making a transition from the Nasdaq Global ...

ALLEGAN -- Perrigo Co. (Nasdaq: PRGO) announced that it has filed an Abbreviated New Drug Application with the U.S. Food and Drug Administration for testosterone topical solution, the generic version ...

Perrigo announced that it has received final approval for Trospium Chloride Extended-Release Capsules, the generic version of Allergan’s Sanctura XR. RELATED: Overactive Bladder & Urinary Incontinence ...

ALLEGAN, Mich. — The Food and Drug Administration has approved a generic drug for incontinence made by Perrigo Co., the drug maker said Wednesday. Perrigo announced the approval of trospium chloride ...

We all want to know what magic goes behind a radiant red carpet complexion. Sourcing the secret back to skincare HELLO! Online speak to Nichola Joss, the celebrity go-to facialist, about why she's ...

Sanctura XR, which is approved for the treatment of overactive bladder (:OAB) with symptoms of urge urinary incontinence, urgency and urinary frequency, posted sales of about $67 million in the 12 ...

Watson Pharmaceuticals, Inc. ( WPI) recently announced that it has gained US Food and Drug Administration (FDA) approval for its generic version of Allergan 's ( AGN) Sanctura XR. The company intends ...